Fake Drinks, Medicines and Food Raise Fresh Questions Over Consumer Safety in Nigeria

Nigeria’s growing battle against counterfeit and substandard consumer products has come into sharper focus following reported enforcement operations in Lagos and Abia states, where authorities uncovered suspected illicit beverage activities and packaging materials bearing the names of established brands.

The discoveries raise an urgent question for consumers: how can Nigerians establish that the drinks they buy, the medicines they depend on and the food they prepare at home are genuine and safe?

The National Agency for Food and Drug Administration and Control (NAFDAC) has intensified enforcement against unsafe and non-compliant products. But the challenge extends beyond identifying suspicious goods. It also involves tracing their sources, dismantling the networks supplying them and preventing potentially dangerous products from reaching consumers.

For households already struggling with rising living costs and healthcare expenses, the consequences can extend far beyond the money lost on a counterfeit purchase.

Lagos Operation Uncovers Suspected Illegal Beverage Facility

One of the latest developments occurred at Zamfara Plaza, within the BBA Trade Fair Complex along the Badagry Expressway in Ojo, Lagos State.

According to reports of the October 13, 2026, operation, NAFDAC investigators uncovered a suspected counterfeit alcoholic beverage operation and arrested two suspects.

The agency said its operation followed intelligence gathering and led officers to premises allegedly being used for illicit beverage-related activities. Subsequent reports described more than 20 illegal stores at the complex, with suspected activities including the blending of drinks, counterfeiting of established brands and the revalidation of expired or unsafe beverages for resale.

Materials reported at the site included bottles, cans, caps, corks, labels and other packaging items. The products and materials seized during the operation were valued at more than ₦2 billion, according to reports citing the agency.

The discovery highlights a serious consumer-protection concern: products that appear to come from familiar manufacturers may have passed through unauthorised handling or repackaging operations.

However, the authenticity and composition of individual recovered products must be established through appropriate investigations and testing. The presence of packaging materials alone does not establish the precise contents or health risks of every product found at a site.

The arrests are also not proof of guilt. The suspects’ alleged roles and any criminal liability remain matters for investigation and due process.

How Counterfeit Packaging Can Mislead Buyers

The reported Lagos operation illustrates why counterfeit beverage investigations cannot focus exclusively on the liquid inside a bottle.

Labels, bottle caps, corks, cartons and other packaging materials can help unauthorised products imitate the appearance of established brands. If such materials are used fraudulently, consumers may have little opportunity to distinguish the contents from genuine products simply by looking at the packaging.

A similar concern emerged from an operation reported in Aba, Abia State, where NAFDAC reportedly recovered large quantities of packaging materials bearing the names of well-known spirits, wines and other consumer products.

The reported materials included branding associated with Jameson, Glenfiddich, Four Cousins, Lord’s Dry Gin, Imperial Blue, Chelsea, Squadron, Seaman’s Aromatic Schnapps and Goya oil.

NAFDAC reportedly estimated the value of materials recovered from five shops at more than ₦200 million. The agency also reported resistance and threats during the operation, while the owners of affected shops were said to have fled.

These findings point to a potential weakness in the wider product supply chain. Counterfeiting can involve multiple stages, from obtaining packaging materials and acquiring genuine empty containers to filling, labelling, storing and distributing unauthorised goods.

Investigators must establish how the materials were obtained, who supplied them, where finished products were intended to go and whether other businesses or distribution networks were involved.

The reported findings in Lagos and Aba do not, by themselves, establish a direct connection between the operations. They nevertheless demonstrate why enforcement agencies need to investigate both suspicious production activities and the supply of materials that could facilitate product imitation.

What Makes Fake Alcoholic Drinks Dangerous?

The risk associated with a counterfeit beverage depends on what it contains, how it was produced, whether it was contaminated and how it was handled.

A product carrying fraudulent branding might contain a genuine drink that has been unlawfully repackaged. Another could be diluted, adulterated, contaminated or manufactured using unsuitable ingredients and unsafe methods.

These situations are not identical, and their health consequences can differ considerably.

One serious hazard associated with illicit alcoholic beverages is methanol contamination. Methanol is toxic, and significant exposure can cause severe poisoning, visual impairment, permanent blindness and death.

Other contaminants may also cause harm. However, it would be misleading to claim that every counterfeit alcoholic drink contains methanol or will necessarily cause organ damage. The composition and risk of a particular product must be established through appropriate testing and medical evidence.

For consumers, the practical problem remains: a convincing label or familiar bottle is not reliable proof that the contents are genuine.

People should avoid consuming beverages suspected of being counterfeit, tampered with or improperly sealed. Where suspected poisoning occurs, urgent medical attention is essential rather than waiting for symptoms to worsen.

Fake Medicines Can Complicate Treatment and Increase Medical Bills

The threat posed by falsified and substandard medicines may be even more difficult for consumers to recognise.

A patient who takes medicine that contains too little of the required active ingredient, the wrong substance or harmful contaminants may fail to receive the intended treatment.

This can be particularly dangerous for people managing malaria, hypertension, diabetes and other conditions requiring effective and consistent medical care.

Nevertheless, treatment failure has several possible causes. Incorrect diagnosis, inappropriate prescriptions, inadequate dosing, poor adherence, drug resistance and complications of an illness can all contribute to a patient’s failure to improve.

A poor response to treatment should therefore prompt proper medical assessment, not an automatic conclusion that the medicine is fake.

The concern is that an ineffective or falsified medicine can become an additional obstacle when a patient is already vulnerable.

For a household paying for consultations, laboratory tests, transport and repeated prescriptions, prolonged illness can place considerable pressure on limited resources. Patients may also lose confidence in their doctors or healthcare facilities without knowing whether the product they used contributed to the problem.

People taking long-term medication should not discontinue or change prescribed treatment on their own. Persistent symptoms or unexpected reactions should be discussed with a qualified healthcare professional, who can assess the treatment and report suspected product-quality problems where appropriate.

Unsafe Food and Unverified Remedies Add to the Risk

The problem of product authenticity extends beyond medicines and alcoholic beverages.

Food products, cooking oils, cosmetics, supplements and other regulated goods can also be affected by adulteration, misleading labelling or improper handling.

A product that looks normal may still require testing before its safety can be established. Appearance, smell and taste cannot reliably detect every harmful contaminant.

The risks can be greater when people purchase products advertised as quick remedies for serious health conditions.

A reported case involving a woman in Ogun State illustrates the potential danger. According to the account, she purchased an advertised herbal product after hearing a radio programme promoting it for suspected fibroids. She reportedly suffered severe pain after using the substance, which was subsequently described as caustic soda.

The precise circumstances and medical findings of that case should be independently confirmed before further conclusions are drawn. Nevertheless, the underlying warning is important: an advertisement or a seller’s assurance does not establish that a substance is safe for human use.

People experiencing reproductive health symptoms or other persistent medical problems should seek qualified medical assessment rather than inserting or ingesting unverified substances.

NAFDAC’s Enforcement Figures Show the Scale of the Challenge

Figures reported from NAFDAC’s Directorate of Investigation and Enforcement indicate that the agency recorded 5,542 enforcement activities between January and August 2026.

During the same eight-month period, the agency reportedly conducted 213 raids, recorded 821 product seizure entries, closed or sealed 179 premises and made 52 arrests.

It also recorded 474 new cases, concluded 295 cases and carried out 22 product destruction exercises.

The reported value of unsafe and non-compliant products destroyed during the period was approximately ₦22.73 billion.

The enforcement figures covered a broad range of regulated products, including medicines, food, drinks, cosmetics, chemicals, packaged water and medical devices.

Monthly figures cited in reports showed enforcement activity reaching 1,089 in July, the highest reported monthly total for the period, followed by 941 in August.

Cosmetics reportedly accounted for 401 product seizure entries, followed by drinks with 215, drugs with 112, food with 69 and chemicals with 22.

These figures demonstrate the breadth of the regulatory workload. They should not, however, be interpreted as a direct measurement of the total number of counterfeit products in circulation or proof that the problem is increasing or declining.

Enforcement activity can reflect changes in intelligence, staffing, reporting, inspection priorities and operational capacity. Assessing the overall impact requires additional information, including the prevalence of unsafe products in markets, repeat-offender rates, prosecution outcomes and evidence that seized supply networks have been disrupted.

Online Shopping Creates Another Verification Challenge

Digital commerce has made it easier for consumers to purchase products through social media pages, online marketplaces and independent sellers.

But a product photograph, customer testimonial or persuasive advertisement cannot establish authenticity.

Buyers may have difficulty confirming a seller’s identity, tracing a product’s origin or checking whether the item delivered matches the product advertised. Sellers can also move between accounts and platforms, making enforcement more complicated.

NAFDAC has previously described efforts to monitor online product sales and improve verification through digital tools and cooperation with online marketplaces.

Consumers can use the agency’s official Greenbook to search its registered-product database. NAFDAC also provides online services for checking product-registration details.

Official verification resources:

• NAFDAC Greenbook: https://greenbook.nafdac.gov.ng/
• NAFDAC official website: https://nafdac.gov.ng/

A registration number should not be treated as conclusive proof of authenticity merely because it appears on a label. Fraudsters may copy details from genuine products. Buyers should compare the information with official records and seek guidance from NAFDAC or a qualified professional when inconsistencies arise.

What Consumers Can Do to Reduce Their Risk

Although the responsibility for controlling counterfeit products rests substantially with regulators, manufacturers, distributors and sellers, consumers can take practical precautions.

For medicines:

• Buy from licensed pharmacies and other legitimate, traceable healthcare supply channels.
• Check the packaging, product name, batch number, expiry date and registration details.
• Be cautious about medicines advertised as miracle cures or sold through unverified accounts.
• Seek professional advice if a product appears altered, causes an unexpected reaction or seems ineffective.
• Do not stop essential prescribed medication without consulting a healthcare professional.

For alcoholic beverages and packaged foods:

• Purchase from reputable retailers and avoid products with broken seals, damaged closures, suspicious labelling or evidence of tampering.
• Be wary of unusually cheap offers when the seller cannot establish the product’s source.
• Do not assume that a familiar bottle or brand label guarantees genuine contents.
• Avoid consuming a product when there is a credible reason to suspect contamination or tampering.

For online purchases:

• Check the seller’s identity and reputation.
• Verify regulated products through official channels where possible.
• Be cautious about exaggerated health claims, pressure to pay immediately and sellers who cannot provide traceable product information.
• Keep receipts, photographs of the packaging and other purchase details if a product needs to be reported.

Consumers should report suspected counterfeit or unsafe products to NAFDAC through its official complaint channels. The agency lists its complaints line as 0800-1-NAFDAC (0800-1-623322). Buyers should confirm current contact details on the official website.

Why Stronger Enforcement Must Go Beyond Raids

The operations in Lagos and Aba, alongside the reported nationwide enforcement figures, raise questions about how Nigeria can make its product-safety system more preventive.

First, regulators need effective market surveillance to identify suspicious products before they reach large numbers of consumers. Registration alone cannot replace ongoing monitoring of manufacturing, storage, transportation, distribution and retail sales.

Second, investigations must extend beyond the premises where products are discovered. Tracing suppliers, distributors, packaging sources and financial links may help authorities identify the wider networks behind suspected counterfeiting.

Third, suspected offenders must face fair, timely investigations and prosecution where evidence supports criminal charges. Seizures and closures can remove immediate hazards, but sustained disruption depends on accountability and preventing the same operations from reappearing elsewhere.

Fourth, healthcare professionals need accessible channels for reporting suspected substandard medicines and unexplained product-related adverse reactions. Such reports can help regulators identify patterns and determine when laboratory testing or a wider investigation is necessary.

Finally, the public needs clear, practical guidance on product verification and reporting. Online marketplaces and legitimate businesses also have a role in preventing prohibited or unsafe goods from being sold through their channels.

The Real Test Is Whether Consumers Become Safer

Nigeria’s reported crackdown has brought suspected illicit beverage activities and potentially fraudulent packaging materials into public view. The reported ₦22.73 billion in destroyed products also highlights the scale of enforcement activity across several regulated sectors.

But the value of goods seized or destroyed is only one part of the picture.

The more important questions are whether investigations identify the people and supply chains responsible, whether repeat offences decline, whether consumers can reliably verify products and whether fewer unsafe goods reach homes, shops and healthcare facilities.

Counterfeit products can cause financial losses, undermine treatment and expose people to substances they never intended to consume. Yet responsible reporting must distinguish confirmed findings from allegations and avoid attributing every illness or treatment failure to counterfeit goods without evidence.

For consumers, vigilance matters. For manufacturers and retailers, traceability and product integrity are essential. For regulators, sustained surveillance, transparent reporting and effective enforcement remain critical.

Ultimately, protecting Nigerians requires a system that does more than remove dangerous products after they have been discovered. It must make it harder for unsafe goods to enter the market in the first place.